Venmax Drugs Live Share Price Today, Share Analysis and Chart

Name: Venmax Drugs & Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Venmax Drugs & Pharmaceuticals Ltd.
Rating: 2.58608325
Author: Trendlyne DVM scores

Iran war impact

Based on the review of the company's latest annual and quarterly reports as of March 2026, the impact of the Iran-Israel war on Venmax Drugs & Pharmaceuticals Ltd. (VENMAX) is considered minimal. The company’s operations and financial hea...

26.69 0.45 (1.71%)

27.79% Fall from 52W High

740

BSE Volume

BSE 10 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Mid Valuation

- / 100

Technically Neutral

58.1 / 100

No estimates available

Venmax Drugs Live Price Chart

Loading Fundamental data..

Loading data..

Is Venmax Drugs & Pharmaceuticals Ltd. worth buying?

8 Votes:

Buy 87.5%

Sell 12.5%

Venmax Drugs Live Share Price Today, Share Analysis and Chart

Based on the review of the company's latest annual and quarterly reports as of March 2026, the impact of the Iran-Israel war on Venmax Drugs & Pharmaceuticals Ltd. (VENMAX) is considered minimal. The company’s operations and financial hea...

27.79% Fall from 52W High

SWOT Analysis

Venmax Drugs Live Price Chart